Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Alphabets quarterly results missed expectations, with slowing Search and ad growth alongside heavy AI infrastructure spending and negative free cash flow weighing on shares despite strong Cloud growth. Traders are debating whether the selloff reflects real risks to Search monetization and spending returns or an overreaction to a strong-growth business, with many bullish voices describing it as a buying opportunity.

Iovances announcement of positive Phase 2 lifileucel results in previously treated metastatic lung cancer, alongside an update on its precision-medicine strategy, is driving attention as traders weigh the therapys potential beyond melanoma. Many are bullish, while others caution that the detailed data still matter and debate whether the sharp move could be followed by profit-taking; short-squeeze talk remains speculative.

Alphabets earnings miss and higher AI-spending outlook have fueled concern about tech valuations and their effect on the broader market, while traders also weigh the Feds rate hold and upcoming inflation and growth data. Bulls point to SPYs resilience and dip-buying, while bears warn of further volatility and downside.

ServiceNows mixed Q3 resultsan earnings miss and a softer forecast for near-term contracted revenue growthsparked a sharp selloff despite revenue growth and a higher AI-contract target. Traders are divided between calling the drop an overreaction to strong underlying demand and warning that slowing growth, high expectations, and AI disruption risks weigh on ServiceNow and the broader software sector.

Alphabets earnings miss and heavy AI infrastructure spending, which pressured cash flow and came alongside slower Search and ad growth, are driving the selloff discussion. Traders are split between concerns about spending returns and AI-driven search competition, and dip-buyers pointing to strong Google Cloud growth and the companys longer-term prospects.

SELLASs Phase 3 REGAL AML trial reached its prespecified 80th event, triggering final analysis and setting up a topline readout expected this quarter; the update did not disclose whether the treatment improved survival. Shares fell sharply, prompting debate over a sell-the-news reaction versus concern about the still-uncertain trial outcome, while bullish traders are focused on the pending data.

Netflixs steep selloff and repeated 52-week lows dominate discussion, with traders pointing to concerns about slower growth, delayed ad rollout and content engagement. Sentiment is split between frustrated bears expecting further declines and investors who see the weakness and lower valuation as a buying opportunity.

SoFis strong third-quarter results and raised outlook are driving attention, with traders pointing to improving growth and analyst upgrades as support for the rally. Bulls are also speculating that elevated short interest could amplify gains, while skeptics question the valuation, dilution and whether the post-earnings momentum can hold.

Microsofts quarterly results beat expectations, with accelerating Azure growth and lower-than-expected capital spending driving a positive reaction and comparisons favoring Microsoft over Alphabet. Traders remain divided over whether strong cloud demand and AI monetization outweigh concerns about free-cash-flow pressure and the stocks fading post-earnings gains.

Alphabets earnings miss and heavy AI-spending concerns sparked debate over whether weakness in the company could weigh on the Nasdaq and broader AI trade. QQQ traders were split between buying the dip and expecting a rebound, and warning that the selloff signaled deeper risks to tech valuations.